WebJun 30, 2024 · CHENGDU, China, and EMERYVILLE, Calif., June 30, 2024 /PRNewswire/ -- Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic ... WebNov 5, 2024 · BEIJING : Chinese COVID-19 vaccine developer Clover Biopharmaceuticals said on Thursday it raised US$240 million in net proceeds in initial public offering (IPO) of shares in Hong Kong.Based on ...
Listing Documents Clover Biopharmaceuticals, Ltd.
WebMar 10, 2024 · Delayed Hong Kong Stock Exchange - 03:08:39 2024-03-10 am EST. 2.150. HKD. -6.52%. 02/20. Clover Bio Signs Exclusive Deal to Distribute Influenza Vaccine in China; Shares Climb 3%. MT. 02/19. Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China. WebClover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China . Clover Launches COVID-19 Booster Vaccine in the … da slice
Vaccine Startup Clover Biopharma Files for Hong Kong IPO
WebJun 8, 2024 · A global clinical-stage biotechnology company, Clover Biopharmaceuticals, focused on discovering, developing and commercializing novel transformative biologic therapies, recently announced the completion of a USD 24 million Series B-2 financing round led by venture capital firm, GL Ventures. The recent funding has brought total the … WebClover Biopharmaceuticals has raised a total of $343.7M in funding over 5 rounds. Their latest funding was raised on Nov 19, 2024 from a Post-IPO Equity round. Clover … WebMar 24, 2024 · Joshua Liang, Chief Executive Officer of Clover Biopharmaceuticals, said, "Dosing the first participants in SPECTRA marks another significant milestone in our journey to develop a COVID-19 vaccine ... das liberale prinzip